Lymphoma patients have better shot at fighting hard-to-beat cancers with MUSC's new cell therapy

Lymphoma patients have better shot at fighting hard-to-beat cancers with MUSC's new cell therapy

Many people who had failed on other cancer therapies for leukemia or lymphoma found success with treatment that removed immune cells and modified them to target their cancer cells. MUSC is working to make it more accurate and less toxic.

The coordinator of the Hematological Cancer Area of the Cancer Center Clínica Universidad de Navarra (CCUN), Dr. Carlos Grande, highlighted that CAR-T cell therapies will reduce the relapse rates of cancer patients, who will also benefit from a more personalized medicine along with new combinations of drugs.

Limited Clinical Insight Poses Barrier to Optimal NHL Treatment: Andrew Evens, DO

Clinical approaches to non-Hodgkin lymphoma in younger and older patient groups generally do not differ, according to Andrew Evens, DO, but he emphasized the need for deeper clinical insights into potential biologic differences in younger oncology patients.

Exportin-1 function may explain blood cancer treatment side effects

The newly discovered functions of exportin-1, a target for blood cancer drugs, may help explain toxicities related to therapy, per a study.

Allogeneic NK Cell Therapy Achieves 92% Response Rate in Lymphoma

Researchers at the University of Texas MD Anderson Cancer Center have reported encouraging safety and efficacy results from a Phase I trial evaluating a novel cell therapy approach involving natural killer (NK) cells complexed with a bispecific antibody. The study, published in Nature Medicine, showed an overall response rate of 92.9% and a complete response of 66.7% in a cohort of 42 heavily pretreated lymphoma patients.  “These data lend to th…

LAU Hematology Conference 2025: Advancing Science Through Interdisciplinary Exchange

Given the complexity and ever-changing nature of blood diseases like multiple myeloma, leukemia and lymphoma, hematology remains at the forefront of medical advancements, with breakthrough research not only improving patient care but also opening the door to potential cures for certain cancers.These cutting-edge findings and the synergistic efforts between disciplines in international cancer care, treatment, and management were the focus of the …